This site is intended for healthcare professionals

Sign in
Go to /sign-in page

You can view 5 more pages without signing in

Griseofulvin and pregnancy

Authoring team

Griseofulvin induces aneuploidy and therefore is a potential teratogen. Therefore it has been advised that both men and women should use contraception whilst taking griseofulvin.

  • men - should avoid fathering children during treatment and up to six months after griseofulvin has been stopped

  • women - should not become pregnant whilst taking griseofulvin or within one month of stopping treatment

Reference:

  • Committee on Safety of Medicines (1996). Griseofulvin: contraceptive precautions. Current Problems in Pharmacovigilance, 22, 8.

Related pages

Create an account to add page annotations

Create a free account

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.